Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.160 | 4.360 | 0.200 |
Shares | 95.840 | 95.840 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.457 | 23.871 |
Price to Book | 2.610 | 4.606 |
Price to Sales | 2.134 | 3.408 |
Price to Cash Flow | 13.031 | 16.464 |
Dividend Yield | 1.388 | 1.249 |
5 Years Earnings Growth | 11.832 | 13.171 |
Name | Net % | Category Average |
---|---|---|
Technology | 26.070 | 27.121 |
Industrials | 18.550 | 11.964 |
Healthcare | 15.890 | 16.117 |
Communication Services | 11.170 | 8.277 |
Consumer Cyclical | 7.470 | 12.395 |
Financial Services | 6.060 | 13.721 |
Real Estate | 5.020 | 1.839 |
Basic Materials | 3.540 | 4.133 |
Utilities | 3.540 | 2.489 |
Consumer Defensive | 2.700 | 7.432 |
Number of long holdings: 79
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ERSTE WWF Stock Environment EUR R01 T | AT0000705678 | 3.58 | 184.390 | -0.71% | |
Microsoft | US5949181045 | 3.26 | 410.37 | +0.99% | |
NVIDIA | US67066G1040 | 2.87 | 135.40 | +1.99% | |
Novo Nordisk B | DK0062498333 | 2.71 | 768.9 | +0.76% | |
Amazon.com | US0231351067 | 2.45 | 197.93 | +6.19% | |
Alphabet A | US02079K3059 | 2.24 | 171.29 | +0.11% | |
ASML Holding | NL0010273215 | 2.18 | 627.10 | +0.95% | |
ERSTE STOCK BIOTEC EUR R01 VT | AT0000746755 | 2.09 | - | - | |
Fiserv | US3377381088 | 1.99 | 202.05 | +2.10% | |
Taiwan Semicon | TW0002330008 | 1.95 | 1,025.00 | -0.49% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AT0000627484 | 580.62M | 22.19 | 9.57 | 12.24 | ||
AT0000627476 | 429.88M | 19.30 | 11.61 | 14.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review